FDA vaccine head will step down in April after string of controversial decisions

Vinay Prasad, director of the Center for Biologics Evaluation and Research, will leave the FDA at the end of April, an agency spokesperson confirmed on Friday.

In an interview with the Wall Street Journal, FDA Commissioner Marty Makary said Prasad had only planned to stay in the role for as long as his one-year leave from the University of California at San Francisco, where he taught before taking the FDA role.

— CNBC’s Angelica Peebles contributed to this report

This is breaking news. Please refresh for updates.